Literature DB >> 19172267

Testing for radioligand sensitivity to endogenous neurotransmitter release.

Gitte M Knudsen.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19172267     DOI： 10.1007/s00259-009-1067-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  17 in total

1.  A PET study of D(1)-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brain.

Authors:  Y H Chou; P Karlsson; C Halldin; H Olsson; L Farde
Journal:  Psychopharmacology (Berl)       Date:  1999-09       Impact factor: 4.530

Review 2.  Neurotransmitter interactions in schizophrenia--therapeutic implications.

Authors:  A Carlsson; N Waters; M L Carlsson
Journal:  Biol Psychiatry       Date:  1999-11-15       Impact factor: 13.382

3.  Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457.

Authors:  Sargo Aalto; Anna Brück; Matti Laine; Kjell Någren; Juha O Rinne
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

4.  Measurement of methylphenidate-induced change in extrastriatal dopamine concentration using [11C]FLB 457 PET.

Authors:  Andrew J Montgomery; Marie-Claude Asselin; Lars Farde; Paul M Grasby
Journal:  J Cereb Blood Flow Metab       Date:  2006-05-10       Impact factor: 6.200

5.  Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method.

Authors:  A Breier; T P Su; R Saunders; R E Carson; B S Kolachana; A de Bartolomeis; D R Weinberger; N Weisenfeld; A K Malhotra; W C Eckelman; D Pickar
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

6.  Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein.

Authors:  Paul Cumming; Dean F Wong; Nicholas Gillings; John Hilton; Ursula Scheffel; Albert Gjedde
Journal:  J Cereb Blood Flow Metab       Date:  2002-05       Impact factor: 6.200

7.  Sequential versus nonsequential measurement of density and affinity of dopamine D2 receptors with [11C]raclopride: effect of methamphetamine.

Authors:  Doris J Doudet; James E Holden
Journal:  J Cereb Blood Flow Metab       Date:  2003-12       Impact factor: 6.200

8.  [18F]altanserin binding to human 5HT2A receptors is unaltered after citalopram and pindolol challenge.

Authors:  Lars H Pinborg; Karen H Adams; Stig Yndgaard; Steen G Hasselbalch; Søren Holm; Heidi Kristiansen; Olaf B Paulson; Gitte M Knudsen
Journal:  J Cereb Blood Flow Metab       Date:  2004-09       Impact factor: 6.200

9.  In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.

Authors:  Rajesh Narendran; Dah-Ren Hwang; Mark Slifstein; Peter S Talbot; David Erritzoe; Yiyun Huang; Thomas B Cooper; Diana Martinez; Lawrence S Kegeles; Anissa Abi-Dargham; Marc Laruelle
Journal:  Synapse       Date:  2004-06-01       Impact factor: 2.562

10.  In vivo evidence for dopamine-mediated internalization of D2-receptors after amphetamine: differential findings with [3H]raclopride versus [3H]spiperone.

Authors:  W Sun; N Ginovart; F Ko; P Seeman; S Kapur
Journal:  Mol Pharmacol       Date:  2003-02       Impact factor: 4.436
View more
  1 in total

Review 1.  Measuring endogenous 5-HT release by emission tomography: promises and pitfalls.

Authors:  Louise M Paterson; Robin J Tyacke; David J Nutt; Gitte M Knudsen
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-28       Impact factor: 6.200
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.